Journal article icon

Journal article

Toremifene interacts with and destabilizes the Ebola virus glycoprotein.

Abstract:

Ebola viruses (EBOVs) are responsible for repeated outbreaks of fatal infections, including the recent deadly epidemic in West Africa. There are currently no approved therapeutic drugs or vaccines for the disease. EBOV has a membrane envelope decorated by trimers of a glycoprotein (GP, cleaved by furin to form GP1 and GP2 subunits) which is solely responsible for host cell attachment, endosomal entry and membrane fusion. GP is thus a primary target for the development of antiviral drugs. Here...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted manuscript

Actions


Access Document


Files:
Publisher copy:
10.1038/nature18615

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Structural Biology
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Human Genetics Wt Centre
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Structural Biology
Role:
Author
More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, NDM, Human Genetics Wt Centre
Role:
Author
Expand authors...
More from this funder
Funding agency for:
Ren, J
More from this funder
Funding agency for:
Ren, J
More from this funder
Funding agency for:
Harlos, KPG
Expand funders...
Publisher:
Nature Publishing Group Publisher's website
Journal:
Nature Journal website
Volume:
535
Pages:
169-172
Publication date:
2016-06-05
Acceptance date:
2016-05-26
DOI:
EISSN:
1476-4687
ISSN:
0028-0836
URN:
uuid:bf711b30-68b8-49b9-a6a8-7236cf6de661
Source identifiers:
631690
Local pid:
pubs:631690
Language:
English

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP